SCHEMBL7959313

SCHEMBL7959313

NC(=O)N(O)CCC1CCC(c2ccccc2)CC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.47
ALOX5 P09917 2/20 0.42
IDO1 P14902 1/20 0.42
ALDH1A1 P00352 1/20 0.42
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
AKR1C3 P42330 1/20 0.41
AKR1C1 Q04828 1/20 0.41
ESR2 Q92731 1/20 0.40
DGAT1 O75907 2/20 0.39
KIF11 P52732 1/20 0.39
KDM4E B2RXH2 2/20 0.39
MEN1 O00255 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carbamic Acid SCHEMBL9679981 0.75 AKR1C3 (0.59) IDO1ALDH1A1MAPTAKR1C3AKR1C1
SCHEMBL9380468 0.75 ALOX5 (0.54) ALOX5ALDH1A1MAPTKDM4E
SCHEMBL9380470 0.75 ALOX5 (0.54) ALOX5ALDH1A1MAPTKDM4E
SCHEMBL28856478 0.74 IDO1 (0.48) CYP2C9IDO1ALDH1A1LMNAMAPT
SCHEMBL7975742 0.74 ALOX5 (0.50) ALOX5AKR1C3AKR1C1
SCHEMBL7975745 0.74 ALOX5 (0.50) ALOX5AKR1C3AKR1C1
SCHEMBL7973281 0.73 AKR1C3 (0.46) ALOX5AKR1C3AKR1C1KDM4ENPC1
SCHEMBL7969786 0.73 AKR1C3 (0.46) ALOX5AKR1C3AKR1C1KDM4ENPC1
SCHEMBL7969789 0.73 AKR1C3 (0.46) ALOX5AKR1C3AKR1C1KDM4ENPC1
SCHEMBL17025385 0.72 ESR2 (0.70) CYP2C9IDO1AKR1C3AKR1C1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6291520-B1 INHIBIT THE ENZYME LIPOXYGENASE; TREATMENT OR ALLEVIATION OF INFLAMMATORY DISEASES, ALLERGIC CONDITIONS AND CARDIOVASCULAR DISEASES PFIZER 2001-09-18 US disclosed